CNBC   |  July 01, 2013

Mallinckrodt CEO Celebrates Spinoff

Marc Trudeau, Mallinckrodt Pharmaceuticals CEO, talks with CNBC about his company's debut on the NYSE and discusses various growth products in its pipeline.

Share This:

Sorry, we do not have a transcript available for this video at this time.